Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Rheumatoid Arthritis
NCT05092984Phase 3Recruiting
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of spironolactone in rheumatoid arthritis (RA), sponsored by Strasbourg University Hospital. Started Jun 2022; status: recruiting.
02
Drugs
spironolactone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05092984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05092984.